Group Gorgé announced four sales of new 3D printers in first-half 2014 to three customers. These machines will be delivered during the financial year, in addition to the three machines previously announced for delivery in 2014.
These new machines were sold in France and Germany, mainly for biomedical production applications but also for research and rapid prototyping.
Two sales concern Prodways' most recent M350 model, and offers the highest productivity levels of the range.
The significance of this sales success is added to by the fact that the sales were set in motion prior to the acquisition of Deltamed, when the Group did not have a proprietary resin solution for 3D printers. The machines will operate using the resins sold by the Group.
Group Gorgé continues its rapid growth in the 3D printing segment, for which it has global ambitions. Prodways, Deltamed and Prodways Entrepreneurs form the main pillars of this business and staff have been increased from one to 66 in the space of a year.
Follow us and be aware of Groupe Gorgé's latest news on Twitter!
Groupe Gorgé - Raphaël GORGÉ -President - Tél. : 01 44 77 94 77 - E-mail : email@example.com
Actus Finance -Anne-Pauline PETUREAUX-Investor Relations - Phone. : (0033)1 53 67 35 74 - mail : firstname.lastname@example.org
Actus Finance -Jean-Michel MARMILLON-Press Relations - Phone : (0033)1 53 67 07 80 - mail : email@example.com
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|GROUPE GORGE||Euronext Paris||20.21||0.55%||10 452|